CALT   $40.16  0.32% Market Closed

Calliditas Therapeutics AB
Total Cash 797.28M
totalCashPerShare 14.762
EBITDA -365.37M
Total Debt 1.01B
quickRatio 2.373
currentRatio 2.686
Total Revenue 1.60B
debtToEquity 944.172
Revenue/Share 59.67
ROA -0.13405
ROE -1.57198
grossProfits
freeCashflow -210.84M
operatingCashflow -244.93M
earningsGrowth
revenueGrowth 1.078
grossMargins 0.93463
ebitdaMargins -0.22815001
operatingMargins -0.05628
profitMargins -0.29996002
enterpriseValue 2.37B
forwardPE 6.3908224
floatShares 6.58M
sharesOutstanding 27.02M
sharesShort 3.49K
sharesShortPriorMonth 6.36K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.30%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 1.977
Price To Book help_outline 20.43
earningsQuarterlyGrowth
netIncomeToCommon -480.36M
trailingEps -1.72%
forwardEps 6.32%
enterpriseToEbitda -6.49
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.22 3Q 2024
institutionsCount 23
lastUpdated Sept. 16, 2024, 7:55 p.m.